KEYNOTE SPEAKERS: Michael Karin Professor, Pharmacology, Tumor Growth Invasion & Metastasis, UCSD FEATURED SPEAKER:
John Sims Scientific Executive Director Inflammation Amgen DISTINGUISHED SPEAKERS:
Linda Burkly, Ph.D. Distinguished Investigator Biogen Idec, Inc.
Fabio Cominelli, M.D., Ph.D. Chief, Division of Gastroenterology and Liver Disease Case Western Reserve University Director, CWRU/UH Digestive Health Center University Hospitals of Cleveland
Raymond Donnelly Senior Investigator FDA
Scott Durum Head, Cytokines and Immunity Section Laboratory of Molecular Immunoregulation NIH, NCI
Simon Fricker Distinguished Scientific Fellow Genzyme Corporation
Jane Grogen Scientist Genentech
Klaus Ley Head, Inflammation Biology La Jolla Institute for Allergy & Immunology
Xiaoxia Li Staff, Department of Immunology Lerner Research Institute Cleveland Clinic
Haishan Lin, Ph.D. Director of Immunology Five Prime Therapeutics, Inc.
Marco Londei Novartis
Erik Lubberts Professor University Hospital Nijmegen/Erasmus Medical Center
Mohamad Navab Professor of Medicine, Cardiology UCLA
Jay Rothstein Director, Inflammation Research Amgen
Benjamin Segal Director, U-M Multiple Sclerosis Center Director, Holtom-Garrett Program in Immunology Professor, Neurology University Of Michigan
Tom Schall President and CEO ChemoCentryx
Julian Symons, D. Phil Head, HCV Biology Roche
Barbara White VP, Clinical Development Inflammatory Disease MedImmune
De Yang, Ph.D. Laboratory of Molecular Immunoregulation NCI, NIH |